2017. ASCO Annual Meeting – Patient experiences with avelumab vs chemotherapy for treating Merkel Cell Carcinoma: Results from protocol-specified qualitative research

Kaufman H, Lambert J, Dias Barbosa C, Guillemin I, Mahnke L, Bharmal M. Patient experiences with avelumab vs chemotherapy for treating Merkel Cell Carcinoma: Results from protocol-specified qualitative research. JCO May 2017;35(15_ suppl):e21065. Presented at: ASCO 2017; June 2-6, 2017: Chicago, IL, USA.